FundedIQ
Biotechnology

Surgicure Technologies: Funding, Investors & Team (Sep 2026)

Surgicure is a biotechnology start-up focused on creating advanced medical devices to enhance safety and efficiency for patients and healthcare providers during surgeries and recovery. Founded by Irena Volkov in 2018, Surgicure Technologies is based in Cambridge, Massachusetts and specializes in securing medical tubes via the patient's oral cavity.

www.surgicuretech.com LinkedIn Cambridge, United States 1-10 employees
Biotechnology Health Care Medical Medical Device
Total raised
$3.5M
Rounds
2
Latest
Seed
Mar 2025

Surgicure Technologies has raised $3.5M across 2 funding rounds on record, the most recent a Seed of $1.8M announced in Mar 2025.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Surgicure Technologies Company Profile and Key Stats

Total funding raised
$3.5M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Seed
$1.8M in Mar 2025
Employees
1-10
reported band
Headquarters
Cambridge, United States

Latest funding round on record: Mar 2025.

Surgicure Technologies Funding Rounds

Date
Round
Amount
Seed
$1.8M
Undisclosed round
$1.7M

Surgicure Technologies raised $1.7M in an undisclosed round announced in Sep 2024.

6 months later, a Seed of $1.8M was announced in Mar 2025.

Surgicure Technologies Founders and Leadership Team

Name
Role
Contact
Irena King
Founder
Locked
Irena Volkov
Founder
Locked

Contact details for the Surgicure Technologies team: 2 of 2 have an email address on file.

Start 14-day free trial →

Surgicure Technologies Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
16,575
$3.1M

Surgicure Technologies' latest round of $1.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Surgicure Technologies in Biotechnology and Cambridge

Companies Similar to Surgicure Technologies

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Surgicure Technologies Funding FAQs

What does Surgicure Technologies do?

Surgicure is a biotechnology start-up focused on creating advanced medical devices to enhance safety and efficiency for patients and healthcare providers during surgeries and recovery. Founded by Irena Volkov in 2018, Surgicure Technologies is based in Cambridge, Massachusetts and specializes in securing medical tubes via the patient's oral cavity.

How much funding has Surgicure Technologies raised?

Surgicure Technologies has raised $3.5M across 2 rounds on record. The most recent is a Seed of $1.8M announced in Mar 2025.

When did Surgicure Technologies last raise funding?

Surgicure Technologies' most recent funding round on record is a Seed of $1.8M, announced in Mar 2025.

Who founded Surgicure Technologies?

FundedIQ lists Irena King (Founder), Irena Volkov (Founder) at Surgicure Technologies.

Where is Surgicure Technologies headquartered?

Surgicure Technologies is based in Cambridge, Massachusetts, United States.

How many employees does Surgicure Technologies have?

Surgicure Technologies is in the 1-10 employee band.

How does Surgicure Technologies' funding compare to other Biotechnology startups?

Surgicure Technologies' latest round of $1.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Surgicure Technologies Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Surgicure Technologies is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.